Atea Pharmaceuticals Inc (AVIR)

전일 마감가:

$3.96

열려 있는:

$3.81

하루 거래량:

723.18K

시가총액:

$312.47M

수익:

$351.37M

순이익/손실:

$-135.96M

주가수익비율:

-2.8984

EPS:

-1.28

순현금흐름:

$-85.40M

1주 성능:

-5.60%

1개월 성능:

-1.33%

6개월 성능:

+25.76%

1년 성능:

+7.54%

1일 변동 폭

$3.645

$3.92

52주 변동 폭

$2.765

$5.19

Atea Pharmaceuticals Inc Stock (AVIR) Company Profile

명칭

Atea Pharmaceuticals Inc

부문

Healthcare (1210)

산업

Biotechnology (699)

전화

857 284 8891

주소

125 Summer Street, Boston

직원

11

트위터

다음 수익 날짜

2024-06-14

최신 SEC 제출 서류

AVIR's Discussions on Twitter

Atea Pharmaceuticals Inc Stock (AVIR) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2023-08-10	다운그레이드	JP Morgan	Neutral → Underweight
2022-01-06	다운그레이드	Morgan Stanley	Equal-Weight → Underweight
2021-11-18	다운그레이드	SVB Leerink	Outperform → Mkt Perform
2021-10-20	다운그레이드	JP Morgan	Overweight → Neutral
2021-10-05	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2020-11-25	개시	Evercore ISI	Outperform
2020-11-24	개시	JP Morgan	Overweight
2020-11-24	개시	Morgan Stanley	Overweight
2020-11-24	개시	William Blair	Outperform

모두보기

Atea Pharmaceuticals Inc 주식(AVIR)의 최신 뉴스

Atea Announces Presentation of Data Highlighting Favorable Safety Profile of Bemnifosbuvir at ESCMID Global 2024

GlobeNewswire Inc.

Atea Pharmaceuticals Completes Patient Enrollment in Global Phase 3 SUNRISE-3 Trial Evaluating Oral Antiviral Bemnifosbuvir for COVID-19 in High-Risk Patients

GlobeNewswire Inc.

Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

GlobeNewswire Inc.

Atea Pharma (AVIR) Gains on Upbeat Initial Data From HCV Study

Zacks Investment Research

Atea Pharmaceuticals' Hepatitis C Virus Candidate Shows Efficacy

Benzinga

Atea Pharmaceuticals Announces Positive Initial Data from Phase 2 Study for Hepatitis C Virus (HCV) and Significant Enrollment Milestone for Phase 3 SUNRISE-3 Trial for COVID-19

GlobeNewswire Inc.

Atea Pharmaceuticals Inc (AVIR) 재무 분석

Atea Pharmaceuticals Inc (AVIR) 매출 2024

Atea Pharmaceuticals Inc (AVIR) 순이익 2024

Atea Pharmaceuticals Inc (AVIR) 현금흐름 2024

Atea Pharmaceuticals Inc (AVIR) 주당 순이익 2024